Sulfonylurea Hypoglycemics Panel (Quantitative), Urine
0091100
Ordering Recommendation
Test may be useful in evaluating if etiology of hypoglycemia is from exposure to sulfonylurea hypoglycemic drugs. However, serum or plasma is the preferred specimen (refer to Hypoglycemia Panel, Sulfonylureas Qualitative, Serum or Plasma (2010292)).
Submit With Order
Mnemonic
SULFON UR
Methodology
Quantitative Liquid Chromatography/Tandem Mass Spectrometry
Performed
Varies
Reported
5-8 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Random urine.  
Specimen Preparation
Transfer 5 mL urine to ARUP Standard Transport Tubes. (Min: 1.2 mL)  
Storage/Transport Temperature
Refrigerated. Also acceptable: Frozen  
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 72 hours; Refrigerated: 2 weeks; Frozen: 6 months  
Reference Interval
By report
Interpretive Data
Note
CPT Code(s)
82542
Components
Component Test Code*Component Chart Name
0090833Chlorpropamide, Urine
0090913Tolazamide, Urine
0090914Tolbutamide, Urine
0090918Glyburide, Urine
0090927Glipizide, Urine
0090928Acetohexamide, Urine
2005825Glimepiride, Urine
2005826Nateglinide, Urine
2005827Repaglinide, Urine
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
Performed at Medtox